Home» Circulars» Viewcirculars Back
 
Webinar on Enhancing opportunities in Pharmaceuticals & Biotech sector between India & the state of Palestine – 10th August 2023
 

 

PxlNwLtrHeaderLogo

 

PXL/HO/Cir-041/2023-24                                                                            Date: 08.08.2023

Hyderabad

 

Dear Sir/Madam,

 

Subject: Webinar on Enhancing opportunities in Pharmaceuticals & Biotech sector between India & the state of Palestine – 10th August 2023

 

We are glad to inform  that the Pharmexcil  in association with the Indian embassy in Palestine is organizing a webinar on “Enhancing opportunities in Pharmaceuticals & Biotech sector between India & the state of Palestine” on 10th August 2023 to guide Indian industry about Palestine regulations & to exploring the opportunities for collaboration and promotion of Indian pharmaceutical drugs in the region.

 

Honorable Minister of Health, State of Palestine H.E. Dr. Mai AlKaileh has consented to join the webinar. The presentations by the Director General of Pharmacy Dr. Tahani Fattouh & Director of Procurement and Supplies Dept., Ministry of Health, State of Palestine Mr. Khaled Mattour, will further elaborate on the significance of the state of Palestine followed by open interaction with select Indian companies. The Agenda of the webinar is enclosed for your perusal.

 

Webinar details are as given below:

 

Webinar on Enhancing opportunities in Pharmaceuticals & Biotech sector between India & the state of Palestine

 

Date & Day                 : Thursday, 10th August 2023

Time                            : 12.30pm - 02.00pm (IST) / 10.00am - 11.30am (Palestine time)

 

Link for registering the webinar:

 

https://pharmexcil.webex.com/weblink/register/r857e92583a12244fe3cac2ec686fb28b

 

Member companies looking forward to establishing their market presence in the state of Palestine are requested to avail this opportunity and join the webinar to gain knowledge on Palestine’s pharma market & regulations for their business enhancement.

 

 

With regards

 

 

Uday Bhaskar

Director General

 

 

Encl: DRAFT AGENDA